Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA

Pat Gulhati, Yekaterina Y. Zaytseva, Joseph D. Valentino, Payton D. Stevens, Ji Tae Kim, Takehiko Sasazuki, Senji Shirasawa, Eun Y. Lee, Heidi L. Weiss, Jianli Dong, Tianyan Gao, B. Mark Evers